The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
Open Access
- 2 January 2009
- journal article
- review article
- Published by Wiley in Journal of Andrology
- Vol. 30 (1), 23-32
- https://doi.org/10.2164/jandrol.108.005751
Abstract
A considerable body of evidence exists suggesting a link among reduced testosterone plasma levels, type 2 diabetes (T2D), and insulin resistance (IR). Hypogonadal men are at higher risk for T2D. Here we evaluate the relationships between testosterone, metabolic syndrome (MetS), T2D, and IR and discuss the relationships among androgen deficiency and these factors, especially as it ultimately relates to the development of cardiovascular disease and erectile dysfunction (ED). Thus, a comprehensive literature search was carried out using PubMed, and relevant articles pertinent to androgen deficiency, T2D, IR, MetS, and ED were reviewed and discussed. Low testosterone precedes elevated fasting insulin, glucose, and hemoglobin A1c (HbA1C) values and may even predict the onset of diabetes. Treatment of prostate cancer patients with surgical or medical castration exacerbates IR and glycemic control, strengthening the link between testosterone deficiency and onset of T2D and IR. Androgen therapy of hypogonadal men improves insulin sensitivity, fasting glucose, and HbA1c levels. We suggest that androgen deficiency is associated with IR, T2D, MetS, and with increased deposition of visceral fat, which serves as an endocrine organ, producing inflammatory cytokines and thus promoting endothelial dysfunction and vascular disease.Keywords
This publication has 95 references indexed in Scilit:
- The Dark Side of Testosterone Deficiency: I. Metabolic Syndrome and Erectile DysfunctionJournal of Andrology, 2009
- Prevalence of hypogonadism in males aged at least 45 years: the HIM studyPublished by Hindawi Limited ,2008
- Inhibition of Luteinizing Hormone Secretion by Testosterone in Men Requires Aromatization for Its Pituitary But Not Its Hypothalamic Effects: Evidence from the Tandem Study of Normal and Gonadotropin-Releasing Hormone-Deficient MenJournal of Clinical Endocrinology & Metabolism, 2008
- Circulating Inflammatory Cytokine Expression in Men With Prostate Cancer Undergoing Androgen Deprivation TherapyJournal of Andrology, 2006
- Sex Differences of Endogenous Sex Hormones and Risk of Type 2 DiabetesJama-Journal Of The American Medical Association, 2006
- Testosterone Restores Diabetes-Induced Erectile Dysfunction and Sildenafil Responsiveness in Two Distinct Animal Models of Chemical DiabetesThe Journal of Sexual Medicine, 2006
- Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunctionBJU International, 2005
- Visceral fat accumulation determines postprandial lipemic response, lipid peroxidation, DNA damage, and endothelial dysfunction in nonobese Korean menJournal of Lipid Research, 2003
- Laboratory Evaluations of Erectile Dysfunction: An Evidence Based ApproachJournal of Urology, 2003
- Testosterone and Regional Fat DistributionObesity Research, 1995